Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 2019;20:663–73.

    Article  CAS  Google Scholar 

  2. Shroff RT, Kennedy EB, Bachini M, et al. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol 2019;37:1015–27.

    Article  Google Scholar 

  3. Kemp Bohan PM, Kirby DT, Chick RC, et al. Adjuvant chemotherapy in resectable gallbladder cancer is underutilized despite benefit in node-positive patients. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08973-x.

    Article  PubMed  Google Scholar 

  4. Nakachi K, Konishi M, Ikeda M, et al. A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). Jpn J Clin Oncol 2018;48:392-5.

  5. Stein A, Arnold D, Bridgewater J, et al. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial): a randomized, multidisciplinary, multinational phase III trial. BMC Cancer 2015;15:564.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Brooke Army Medical Center, 3551 Roger Brooke Dr., Fort Sam Houston, TX, 78234, USA

    Phillip M. Kemp Bohan MD

  2. Department of Surgery, William Beaumont Army Medical Center, 5005 N. Piedras St., El Paso, TX, 79920, USA

    Daniel W. Nelson DO

Authors
  1. Phillip M. Kemp Bohan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel W. Nelson DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel W. Nelson DO.

Ethics declarations

Disclosures

Phillip M. Kemp Bohan and Daniel W. Nelson declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bohan, P.M.K., Nelson, D.W. ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data. Ann Surg Oncol 28, 1481–1482 (2021). https://doi.org/10.1245/s10434-020-08979-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08979-5

Search

Navigation